๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Etoposide (VP16-213) in the treatment of advanced nasopharyngeal carcinoma

โœ Scribed by Shiu, Wesely C.T.; Tsao, Shiu Y.

Book ID
123410761
Publisher
Elsevier Science
Year
1988
Weight
146 KB
Volume
24
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Cisplatin plus VP16-213 in advanced ovar
Cisplatin plus VP16-213 in advanced ovarian carcinoma
โœ P.R. Harnett; D.R. Bell; B.L. Hillcoat; R.L. Woods; J.A. Levi; R.M. Rome; J.C. C ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 281 KB
Vincristine, adriamycin, cyclophosphamid
Vincristine, adriamycin, cyclophosphamide, and etoposide (VP16-213) in small-cell anaplastic carcinoma of the lung
โœ F. E. Eyben; ร…. Arwidi; C. Hellekant; K. Jonsson; S. ร…. Lindahl; W. Mattsson; L. ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› Springer ๐ŸŒ English โš– 299 KB

Twelve patients with small-cell anaplastic carcinoma of the lung were treated with vincristine 1 mg/m2 i.v. day 1, adriamycin 50 mg/M2 i.v. day 1, cyclophosphamide 1,000 mg/m2 i.v. day 1, and etoposide 80 mg/m2 i.v. day 2, 4, 6 given on an outpatient basis and repeated at 3-week intervals. As consol